德尤比奎丁酶USP47 通过减少蛋白O-GlcNAcylation改善心脏缩
Yu Jiang1, Wenyao Cai1, Guangtao Lei2
1Department of Cardiovascular Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China ; and.
德尤比奎丁酶USP47通过稳定PRMT5来保护心脏缩,该PRMT5调节了O-GlcNAcase的表达. USP47代表了治疗这种心脏病的潜在治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 疾病的分子机制.
- 乌比奎丁-蛋白酶体系统
背景情况:
- 心脏缩是心力衰竭的主要危险因素.
- 乌比奎丁-蛋白酶体系统与心脏缩病变的发生有关.
- 在心脏缩中脱化酶的作用尚不清楚.
研究的目的:
- 为了研究duebiquitinase USP47在心脏缩中的作用.
- 阐明USP47影响心脏缩的分子机制.
- 为了确定USP47是否是一种潜在的治疗点.
主要方法:
- 评估USP47表达在过度缩的心脏和心肌细胞.
- 利用腺病毒介导的功能增益和丧失方法.
- 研究了USP47对O-GlcNAcylation的调节及其与PRMT5.5的相互作用.
主要成果:
- USP47表达在过度缩条件下升高.
- USP47的过度表达减轻了心脏缩,而USP47的缺乏加剧了心脏缩.
- USP47稳定了PRMT5,提高了O-GlcNAcase的调节,并抑制了O-GlcNAcylation.
结论:
- USP47对心脏缩起着保护作用.
- USP47通过PRMT5-O-GlcNAcase轴进行作用.
- USP47是心脏缩的潜在治疗标.
更多相关视频
10:25Monitoring of Ubiquitin-proteasome Activity in Living Cells Using a Degron dgn-destabilized Green Fluorescent Protein GFP-based Reporter Protein
Published on: November 10, 2012
07:05Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay
Published on: September 27, 2024
相关概念视频
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Unfolded Protein Response
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Protein Modifications in the RER
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
